Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
X-37 logo — Utilizing advanced AI to discover new drug candidates by sca...

X-37

Utilizing advanced AI to discover new drug candidates by scanning extensive libraries of chemical compounds against prime pharmaceutical targets.

Founded 2018 2-10 employees Series A Total: $14.50M AI, Health Care +1

General Information

Company Name X-37
Founded Year 2018
Employees 2-10
Industries AI, Health Care, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with X-37. To contact X-37, visit x37.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About X-37

X-37 is a cutting-edge pharmaceutical discovery and development company founded in 2018. The startup is focused on revolutionizing the pharmaceutical industry by leveraging advanced AI technology from Atomwise, Inc. to identify new drug candidates. Their groundbreaking approach involves scanning extensive libraries of chemical compounds against high-value pharmaceutical targets, which holds immense promise for the future of drug discovery. The most recent investment of $14.50M was secured in a Series A round from a consortium of prominent investors, including Alpha Intelligence Capital, Hemi Ventures, and DCVC Bio, on 14 November 2019. This significant financial backing underlines the confidence in X-37's vision and underscores their potential to make a substantial impact in the Health Care and Pharmaceutical industries.

Taxonomy: Pharmaceutical discovery, Drug development, Chemical compounds, Novel drug candidates, Artificial intelligence, Pharmaceutical targets, Drug discovery, Medicinal chemistry, AI drug screening, Machine learning, Pharmaceutical research, Medical technology, Biopharmaceuticals

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A X $14.50M 3
Alpha Intelligence Capital Hemi Ventures
Alpha Intelligence Capital, Hemi Ventures +1
14 Nov 2019
Seed Round X Undisclosed 1
DCVC Bio
01 Dec 2018

X-37 Alternatives & Competitors

View All Alternatives
X-37 vs
Atomwise
Atomwise United States

Better Medicines Faster

Grant
13 employees
AI, Biotechnology
X-37 vs
Design Pharmaceuticals Inc.
Design Pharmaceuticals Inc. United States

Boundless GPCR drug discovery

Seed
3 employees
Biotechnology, Health Care
X-37 vs
Exo Therapeutics
Exo Therapeutics

Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technolog...

Series B
11-50 employees
Biotechnology, Health Care
View all alternatives

FAQ About X-37

Utilizing advanced AI to discover new drug candidates by scanning extensive libraries of chemical compounds against prime pharmaceutical targets.
X-37 was founded in 2018.
X-37 operates in AI, Health Care and Pharmaceutical. Its work centres on Pharmaceutical discovery, Drug development, Chemical compounds and Novel drug candidates.
X-37 has approximately 2-10 employees.
X-37 has completed 2 funding rounds, raising a total of $14.50M. The latest funding stage is Series A.
Top alternatives and competitors to X-37 include Atomwise, Design Pharmaceuticals Inc., Exo Therapeutics, BeBetter Med, iktos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
X-37 and Atomwise are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for X-37, https://bouncewatch.com/company/x-37-1, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes